Navigation Links
Researchers advance understanding in immune response to infectious disease
Date:7/16/2014

University of Leicester researchers have released evidence substantiating an unexpected dual role of an important component of the immune system.

Findings by researchers at the University's Department of Infection, Immunity and Inflammation including three PhD graduates are published in a paper for the journal 'Medical Microbiology and Immunology'.

The paper presents significant new findings about the protein properdin an important part of the immune system. It is a positive regulator in the alternative pathway of complement activation which means it plays a key part in one of the body's main techniques for tackling infections and foreign bodies known as antigens.

The new findings show that in some situations a lack of properdin can actually have major benefits while in others it can be a big disadvantage.

Using mouse models, the researchers investigated the differences in immune responses between individuals deficient in properdin and those with normal amounts of the protein.

When individuals were infected with Streptococcus pneumoniae - bacteria which can cause sepsis and pneumonia in humans those deficient in properdin had higher survival rates than those with normal levels.

But when individuals were infected with Listeria monocytogenes which cause an infection called listeriosis in humans those deficient in properdin had lower levels of survival.

Cellular analysis by the researchers suggests that properdin-deficiency is likely to cause the body to use more of a type of white blood cell known as M2 macrophages involved in tissue repair rather than M1 macrophages, whose main role is to kill pathogens.

This allowed the researchers to conclude that properdin controls the strength of the body's immune response by affecting the role of macrophages during infection and inflammation.

Principal investigator and corresponding author, Dr Cordula Stover, Senior Lecturer in Immunology at the University's Department of Infection, Immunity and Inflammation, said: "The PhD graduates' projects together elucidate a critically instructive role of an innate immune protein, complement properdin, in shaping the inflammatory response.

"The work is the first to show that complement properdin controls the strength of immune responses by affecting humoral as well as cellular phenotypes during acute bacterial infection and ensuing inflammation."

Dr Stover also stresses that using mouse models can be very useful for understanding disease mechanisms but there are limitations with the value of mouse models.

She said: "We are asking mice to react to human pathogens or diseases of significance for man, not mouse. Mice are genetically homogenous, unlike man, and have comparable, not identical, scope of cells and antibodies.

"To be meaningful, disease concepts need to be tested in patient samples, in order to have direct application of the research."


'/>"/>

Contact: Cordula Stover
cms13@le.ac.uk
01-162-525-032
University of Leicester
Source:Eurekalert

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. UNH researchers find African farmers need better climate change data to improve farming practices
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
7. Researchers print live cells with a standard inkjet printer
8. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
9. Researchers reveal how a single gene mutation leads to uncontrolled obesity
10. Researchers discover novel therapy for Crohns disease
11. New paper by Notre Dame researchers describes method for cleaning up nuclear waste
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: